Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19

por Ghazanfari, Davoud, Courreges, Maria Cecilia, Belinski, Lydia, Bergmeier, Stephen C., McCall, Kelly D., Goetz, Douglas J.
Publicado 2022